Purpose. Lung cancer tissue includes tumor tissue, stromal cells, immune cells, and epithelial cells. These nontumor cells dilute the tumor purity in lung cancer tissues. Tumor purity plays an essential role in the immune response to lung cancer. At present, the biological processes related to the purity of lung cancer tumors remains unclear. Methods. We measured tumor purity in 486 lung carcinoma tissues from TCGA-LUAD FPKM by using the “estimate” R package. Lung carcinoma tumor mutation burden was calculated by analyzing TCGA single nucleotide polymorphism data. The immune cell proportion was also evacuated via the CIBERSORT method. Lung carcinoma samples with P<0.05 were considered significant. Based on the tumor purity and lung carcinom...
Numerous efforts have been made to elucidate the etiology and improve the treatment of lung cancer, ...
Numerous efforts have been made to elucidate the etiology and improve the treatment of lung cancer, ...
Lung adenocarcinoma is the most frequently diagnosed subtype of nonsmall cell lung cancer. The molec...
Surgical archives of tumor specimens are often impure. The presence of RNA transcripts from nontumor...
BackgroundCancer stem cells (CSCs) refer to cells with self-renewal capability in tumors. CSCs play ...
Introduction: Non-small-cell lung cancer exhibits a range of transcriptional and epigenetic patterns...
The tumour microenvironment is the non-cancerous cells present in and around a tumour, including mai...
BACKGROUND: The tumor immune microenvironment is a heterogeneous entity. Gene expression analysis al...
Q1Q1The bioinformatic pipeline previously developed in our research laboratory is used to identify p...
Background. Lung adenocarcinoma (LUAD) comprises around 40% of all lung cancers, and in about 70% of...
Lung tissue is abundant with immune cells that form a powerful first defense against exotic particle...
Abstract Background Accumulative evidence shows that an organoid is a more practical and reliable to...
BackgroundCD8+ T cells are one of the central effector cells in the immune microenvironment. CD8+ T ...
Background Lung cancer remains the world-wide leading cause of cancer morbidity and mortality as a ...
Summary: The immunogenomic features of tumor-adjacent lungs (TALs) in stage I lung squamous cell car...
Numerous efforts have been made to elucidate the etiology and improve the treatment of lung cancer, ...
Numerous efforts have been made to elucidate the etiology and improve the treatment of lung cancer, ...
Lung adenocarcinoma is the most frequently diagnosed subtype of nonsmall cell lung cancer. The molec...
Surgical archives of tumor specimens are often impure. The presence of RNA transcripts from nontumor...
BackgroundCancer stem cells (CSCs) refer to cells with self-renewal capability in tumors. CSCs play ...
Introduction: Non-small-cell lung cancer exhibits a range of transcriptional and epigenetic patterns...
The tumour microenvironment is the non-cancerous cells present in and around a tumour, including mai...
BACKGROUND: The tumor immune microenvironment is a heterogeneous entity. Gene expression analysis al...
Q1Q1The bioinformatic pipeline previously developed in our research laboratory is used to identify p...
Background. Lung adenocarcinoma (LUAD) comprises around 40% of all lung cancers, and in about 70% of...
Lung tissue is abundant with immune cells that form a powerful first defense against exotic particle...
Abstract Background Accumulative evidence shows that an organoid is a more practical and reliable to...
BackgroundCD8+ T cells are one of the central effector cells in the immune microenvironment. CD8+ T ...
Background Lung cancer remains the world-wide leading cause of cancer morbidity and mortality as a ...
Summary: The immunogenomic features of tumor-adjacent lungs (TALs) in stage I lung squamous cell car...
Numerous efforts have been made to elucidate the etiology and improve the treatment of lung cancer, ...
Numerous efforts have been made to elucidate the etiology and improve the treatment of lung cancer, ...
Lung adenocarcinoma is the most frequently diagnosed subtype of nonsmall cell lung cancer. The molec...